• A New ‘Force’ in Injectable Drug Delivery

    A new approach to delivering injections could ease administration and open up design possibilities.Daphne AllenDeveloping delivery devices for injectable drugs has never been as challenging as it is today. Thanks to changing healthcare models, a growing number of patients are being asked to self-administer therapies for cancer, arthritis, multiple sclerosis, and other chronic illnesses. But patients aren’t professionals. “Patients who will need to take injections are not familiar with using a...
  • And the XPRIZE Goes to . . .

    A Pennsylvania-based team invented a diagnostic tool inspired by Star Trek and landed millions of dollars to bring it to market. Nancy CrottiFinal Frontier Medical Devices won the Qualcomm Tricorder XPRIZE for its DxtER prototype device. A family of engineers and doctors has taken their commitment to science and technology, and devotion to a futuristic TV show, to boldly go where no one has gone before—they invented an actual Tricorder.Final Frontier Medical Devices, made up of...
  • Should BD Investors Get Over Their Bard Sticker Shock?

    Becton, Dickinson and Company (BD) gave a lot of shareholders sticker shock Sunday with the news of its $24 billion pending acquisition of C.R. Bard Inc. But this isn’t BD’s first blockbuster M&A rodeo, and both management teams painted a pretty interesting picture of what the combined entity could look like.Amanda Pedersen It’s easy to understand why investors would have a case of sticker shock over the news of Becton, Dickinson and Company’s (BD) $24 billion pending acquisition of C....
  • Are Ingestible Sensors the Answer to Medication Adherence Problems?

    Digital medicine, with an ingestible sensor at its core, could go a long way toward improving medication adherence.Andrew Kelly Proteus Discover, developed by Proteus Digital Health, is designed to improve medical adherence using ingestible sensors, a wearable device, and mobile technology.“Drugs don’t work in patients who don’t take them.”  According to former Surgeon General C. Everett Koop, the medication adherence problem is simple and obvious. The solution, unfortunately, is not...
  • How J&J is Boning Up on 3-D Printing

    Johnson & Johnson’s DePuy Synthes has acquired an early-stage 3-D printing technology aimed at healing bone defects.Amanda PedersenThe industry has only just scratched the surface of bringing 3-D printing into the medical arena, but a recent Johnson & Johnson acquisition is an indicator of the ultimate promise the technology holds for medtech. Find out which emerging technologies physicians and hospitals are excited about at the BIOMEDevice Boston Conference, May 3-4, 2017.J&J'...
  • Could One Test Help Combat a Massive Problem?

    MeMed Ltd has been awarded a $9.2M Department of Defense contract to support a rapid point-of-care test designed to distinguish between bacterial and viral infections, ultimately helping to mitigate the misuse of antibiotics.Kristopher SturgisMeMed's second-generation point-of-care test is designed to distinguish between bacterial and viral infections within 15 minutes. The technology could play an important role in the global fight against antibacterial drug resistance. A relatively new...
  • Measure Biomarkers with a Wearable Device? No Sweat

    Researchers have built a device to induce perspiration and measure health indicators like blood glucose on demand.Nancy CrottiThis wearable device, developed by Stanford University researchers, is designed to extract and analyze sweat to monitor health and disease. Many of the biomarkers clinicians gain access to through a blood draw can actually be quantified in sweat itself. However, it’s neither easy, nor necessarily advisable, to make sedentary or critically ill patients work up a...
  • Lower Volume, Value for Recent Med Device M&A

    In the medical device subsector, both the volume and total value of deals in the first quarter of 2017 were lower than in the prior and year ago quarters.Marie ThibaultVenture capital funding for medical device companies may have rallied during the first quarter of 2017, but deal volume and value for mergers and acquisitions for the medtech industry declined during the same time period.Deal value for life sciences mergers and acquisitions announced in the first quarter of 2017 rose, according...
  • Will Abbott Be Able to Fix-and-Flip Alere?

    Abbott CEO Miles White sees Alere as “a fixer-upper,” and said the company will divest some parts of the business after the amended deal closes.Amanda Pedersen Abbott CEO Miles White isn’t one to tiptoe around the elephant in the room. So, when it came time for questions during the company’s first-quarter earnings call Wednesday, White was ready to talk about Alere.“Look, the company had some challenges, we all know that, and it’s a bit of a fixer-upper,” he said.Learn about the latest...
  • How Abbott is 'All Over Everything' in FDA Warning

    Abbott CEO Miles White told investors that the company is "all over everything" in its recent FDA warning letter, and that the company will be looking at all of its manufacturing plants, not just the Sylmar, CA-based facility addressed in the letter.Amanda Pedersen Abbott Laboratories smashed first-quarter sales and profit expectations after acquiring St. Jude Medical in early January, but the company’s strong financial performance was overshadowed Wednesday by questions related to a...
  • The Latest on J&J’s Device Strategy

    Johnson & Johnson executives offer insights into their view for the company’s medical device business, which is undergoing a transformation.Marie ThibaultJohnson & Johnson’s latest medical device transactions pale in size compared to the company’s $30 billion deal to pick up Actelion and its 2012 $20 billion acquisition of Synthes. Is there any potential for Johnson & Johnson to go after a large device acquisition?The healthcare giant has announced a few medical device acquisitions...
  • Will Medtronic Deal Ease Cardinal's Deflation Pains?

    Cardinal Health’s $6.1 billion deal for three Medtronic businesses is everything the company hoped it would be, but the stock plunged anyway based on lowered earnings guidance.Amanda Pedersen  Cardinal Health Inc. has had eyes on certain parts of Medtronic’s patient monitoring and recovery division since before the assets were even owned by Medtronic. Now, Cardinal is betting good money – $6.1 billion, in fact – that an acquisition of Medtronic’s patient care, deep vein thrombosis,...
  • Baxter Under Criminal Investigation for Possible Price Fixing

    A Baxter employee has received a grand jury subpoena in connection with a criminal investigation into the company's IV saline business.Amanda Pedersen  Baxter Inc.’s shares slipped Monday, the first trading day after the company disclosed Friday in an SEC filing that one of its employees has been subpoenaed in connection with a Department of Justice criminal investigation into the company’s IV saline business.Don't miss BIOMEDevice Boston, May 3-4, 2017.In February, Baxter reported...
  • Abbott Has More Trouble to 'Absorb' with Bioabsorbable Stent

    Abbott said it will monitor bioabsorbable stent implantations in Europe, following a high rate of heart attacks in European Absorb GT1 patients, plus a separate FDA safety alert regarding adverse events associated with the device.Nancy CrottiA high rate of heart attacks in European patients following implantation of its Absorb GT1 bioabsorbable drug-eluting stent has prompted Abbott Laboratories to begin monitoring surgeons’ implantation techniques.Learn about the latest design strategies and...
  • Abbott and Alere Mend Fences – and Merger

    After a year of fighting and lawsuits, Abbott Laboratories and Alere Inc. have agreed to make up and tie the knot after all – in a new deal worth about $5.3 billion.Amanda Pedersen  Breaking up is hard to do, especially when a multi-billion contract is at stake.Perhaps that realization is what ultimately motivated Abbott Laboratories and Alere Inc. to finding some common ground, and reconciling a merger agreement that is now valued at $5.3 billion, down from the original price of $5.8...
  • Will Abbott Have to Pay for St. Jude’s Mistakes?

    Abbott is in hot water with FDA over St. Jude Medical’s past mistakes, including what was either a lie of omission – or worse.Amanda Pedersen  At best, St. Jude Medical management pussyfooted around the truth back in 2014 during the handling of an ICD battery problem that eventually resulted in a major recall last year. At worst, company leaders didn’t just omit the truth – they lied.In a detailed FDA warning letter to Abbott this week, the agency faulted the company for its handling...
  • FDA Takes Abbott to Task for ‘Hazardous Situation’

    FDA is taking Abbott Laboratories to task for essentially downplaying manufacturing flaws and cybersecurity concerns related to devices acquired through its $25 billion purchase of St. Jude Medical.Amanda Pedersen  It seems Abbott Laboratories acquired more than it might have bargained for when it paid $25 billion for St. Jude Medical earlier this year. The company also inherited a slew of poorly-handled manufacturing problems at the company's Sylmar, CA facility.Learn about risk...
  • Glaukos Eyes Early Promise in New IOP Sensor

    Glaukos Corp., known for developing innovative new technologies designed to treat glaucoma, has acquired a new early-stage sensor technology from DOSE Medical, dubbed the intraocular pressure sensor system.  Kristopher Sturgis Glaukos Corp. continues to establish itself as a leader in the glaucoma technology space. This week the company acquired DOSE Medical Corporation’s intraocular pressure (IOP) sensor system — a new wireless system designed to transform glaucoma therapy through...
  • Electric Field Treatment May Boost Pancreatic Cancer Survival Rates

    A European study of Novocure's tumor-treating fields technology yielded encouraging results for patients with a deadly cancer.Nancy Crotti  A recent small study of low-intensity, alternating electric fields in treating pancreatic cancer suggests longer survival times.Novocure (St. Helier, Jersey) recently completed a feasibility, safety, and preliminary efficacy pilot study of its tumor-treating fields (TTFields) technology in 40 patients with advanced pancreatic cancer. Half of the...
  • A New Solution for Packaging Two Catheters Emerges

    Two catheters or guidewires can be combined on one card, saving material and space.Daphne AllenAn award-winning solution for packaging catheters in flexible formats has just been adapted to hold two catheters and/or guidewires. The Dual Hoop Catheter DISK (Dispenser Integrated System Kit) by CleanCut Technologies features a clipless catheter and guidewire dispenser bonded to a HDPE backer card. Adapted from the company’s original DISK design, which won a Medical Device Excellence Award in 2014...